PAYS - Paysign GAAP EPS of $0.00 beats by $0.01 revenue of $8.6M misses by $0.23M
- Paysign press release ( NASDAQ: PAYS ): Q2 GAAP EPS of $0.00 beats by $0.01 .
- Revenue of $8.6M (+29.3% Y/Y) misses by $0.23M .
- Paysign CFO Jeff Baker said, "With the large number of plasma donation centers we added this quarter, we now expect our total revenue to grow 27.5% over 2021, coming in at the high end of our guidance range of $35.25 million to $38.35 million with upside to that range if some of the headwinds mentioned above abate. Plasma is estimated to make up about 92% of total revenues for 2022. We expect Q3 2022 total revenues to be approximately $10.2 million and Q4 2022 total revenues to be approximately $10.5 million despite two pharma prepaid programs ending in mid-November.
- Consensus Revenue Estimate for Q3: $9.57M, for Q4: $10.34M and 2022 is $36.96M.
For further details see:
Paysign GAAP EPS of $0.00 beats by $0.01, revenue of $8.6M misses by $0.23M